Virginia SedenoMonge

Dr. Virginia SedenoMonge


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 June 2014 in Journal of Neuroimmunology
Verified
Journal Article
Closed access
PDF file
VSVirginia SedenoMonge
Virginia SedenoMonge
RARaúl Arcega-Revilla
Raúl Arcega-Revilla
Emmanuel Rojas MoralesEmmanuel Rojas Morales
Emmanuel Rojas Morales
Gerardo Santos-LopezGerardo Santos-Lopez
Gerardo Santos-Lopez
JPJuan Carlos Perez-García
Juan Carlos Perez-García
JRJulio Reyes-Leyva
Julio Reyes-Leyva

1 March 2020 in Gaceta Médica de México
Verified
Journal Article
Closed access
JMJosé M. Madrazo-Cabo
José M. Madrazo-Cabo
GLGrecia A. León-Durán
Grecia A. León-Durán
AOAdriana Oliveros-Montiel
Adriana Oliveros-Montiel
JLJosé A. Ledesma-Montes
José A. Ledesma-Montes
IMIván D. Morales-González
Iván D. Morales-González
VSVirginia SedenoMonge
Virginia SedenoMonge
Introduction: Pregnancies resulting from assisted reproductive technologies (ART) have been documented to have a higher risk of adverse effects. Objective: To provide evidence on obstetric and perinatal complications associated with conceptions by ART versus spontaneous pregnancies. Method: Comprehensive review of original articles published between 2010 and 2018 addressing the more common obstetric and perinatal complications in pregnancies resulting from in vitro fertilization (OVF) and intracytoplasmic sperm injection (ICSI), in comparison with spontaneous conceptions. Results: Thirty-seven original articles, which reported on 26 cohort studies and 11 case-control trials, were included. IVF and ICSI conceptions were associated with a larger number of obstetric and perinatal complications such as low birth weight, prematurity, low weight for gestational age, admission to the neonatal intensive care unit, congenital malformations, C-sectionand premature rupture of membranes, among others. Conclusions: Pregnancies by ART are associated with an increased risk of obstetric and perinatal complications in comparison with spontaneous conceptions. Further research is needed to determine which aspects result in higher risk.

19 June 2024 in Scientia Pharmaceutica
Verified
Journal Article
Open access
PDF file
LDLuis Márquez Domínguez
Luis Márquez Domínguez
CMCarolina Jasso Miranda
Carolina Jasso Miranda
VSVirginia SedenoMonge
Virginia SedenoMonge
Gerardo Santos-LopezGerardo Santos-Lopez
Gerardo Santos-Lopez
Influenza poses a significant threat to public health worldwide, particularly among vulnerable populations such as children, the elderly, immunocompromised individuals, and those with chronic diseases. It is associated with high mortality and morbidity rates. Neuraminidase inhibitors play a crucial role in influenza treatment by mitigating the risk of complications and death. However, the genetic variability of the influenza virus enables the emergence of drug-resistant mutations. This review focuses on the search for new compounds that are not analogous to sialic acid, aiming to inhibit the activity of viral neuraminidase in vitro, viral replication in cell cultures, or animal models. Influenza virus strains that have been reported in the literature present specific mutations that generate resistance to neuraminidase inhibitors. Since these inhibitors bear structural resemblance to sialic acid, the predominant location for these mutations is the enzyme’s active site. Consequently, exploring alternative compound classes becomes imperative to circumvent this interaction pattern. These compounds will introduce diverse molecular frameworks, serving as foundational structures for further development through rational drug design, thereby engendering novel antiviral agents targeting influenza. The potential prospects for developing novel influenza antivirals based on these findings are discussed.

6 March 2025 in American Journal of Case Reports
Verified
Journal Article
Open access
JCJosé Manuel Madrazo Cabo
José Manuel Madrazo Cabo
AFAnia Villavicencio Flores
Ania Villavicencio Flores
PGPaulina Chagollán Gudiño
Paulina Chagollán Gudiño
NVNuvia Adriana Monter Valera
Nuvia Adriana Monter Valera
JBJose Antonio Velasco Bárcena
Jose Antonio Velasco Bárcena
VSVirginia SedenoMonge
Virginia SedenoMonge
Rare coexistence of disease or pathology Antiphospholipid syndrome (APS) is an immune system disorder that causes an increased risk of blood clots and has been associated with the development of hypothyroidism and double mitral lesion, possibly due to immune complex deposition. This report describes a 34-year-old woman presenting with hypothyroidism and antiphospholipid syndrome with a double mitral lesion at 26 weeks of gestation. We report the case of a 34-year-old woman with a history of hyperthyroidism that evolved into primary hypothyroidism, as well as APS under medical treatment, and fetal death during her first pregnancy. Subsequently, at 26 weeks of gestation in her second pregnancy, she presented a clinical picture of respiratory failure and precordial pain, which persisted with the same intensity and location despite postural changes for 2 days; after that, she had an increase in chest pain with irradiation to the front part of the chest, progressing to orthopnea. She was evaluated in the emergency room by Cardiology, where an echocardiogram was performed, which showed a double mitral lesion. The decision was made to admit her to intensive care with this diagnosis and pulmonary edema and establishing the specific treatment. She remained under obstetric surveillance and cardiovascular treatment until she was discharged. She maintained maternal-fetal stability cardiologic and endocrinological care, allowing the pregnancy to be successfully carried out to term without complications, and she and her baby showed very good perinatal results during the postpartum period. This report highlights the importance of timely and accurate diagnosis of antiphospholipid syndrome and highlights the association with both hypothyroidism and double mitral lesion.

27 May 2026 in Human Immunology
Verified
Journal Article
Closed access
VSVirginia SedenoMonge
Virginia SedenoMonge
Gerardo Santos-LopezGerardo Santos-Lopez
Gerardo Santos-Lopez
EBElizabeth Bautista
Elizabeth Bautista
Nora Hilda Rosas-MurrietaNora Hilda Rosas-Murrieta
Nora Hilda Rosas-Murrieta
ARAdriana Hernández Reyes
Adriana Hernández Reyes
MPMoisés Manuel Gallardo Pérez
Moisés Manuel Gallardo Pérez